Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Halozyme Therapeutics Inc (NASDAQ:HALO)

9.88
Delayed Data
As of 4:00pm ET
 +0.08 / +0.82%
Today’s Change
6.96
Today|||52-Week Range
19.63
-42.99%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
AssetsCash--21.6M61.4M43.3M
 
 
 
 
Short Term Investment Cash47.1M-72.0M34.0M-18.1M
 
 
 
 
 
Cash & Short Term Investments99.9M71.5M135.6M108.3M
 
 
 
 
 
 
ReceivablesReceivables15.7M9.1M9.1M32.4M
 
 
 
 
 
 
InventoriesInventories2.7M6.2M6.4M9.5M
 
 
 
 
 
 
Current AssetsOther Current Assets12.8M8.4M10.1M21.5M
 
 
 
 
 
Current Assets131.0M95.2M161.3M171.8M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross10.4M11.1M12.2M14.3M
 
 
 
 
 
Depreciation-6.7M-7.6M-9.2M-10.3M
 
 
 
 
 
Other Assets0.002.7M1.2M5.6M
 
 
 
 
Total Assets134.7M101.8M166.0M181.8M
 
 
 
 
 
 
LiabilitiesAccounts Payable2.3M3.1M3.0M4.5M
 
 
 
 
 
Short Term Debt0.000.000.0021.9M
 
 
Accrued Expenses3.7M7.8M8.0M18.2M
 
 
 
 
 
Other Current Liabilities12.6M15.2M15.4M27.5M
 
 
 
 
 
Other Liabilities18.9M25.5M24.3M62.5M
 
 
 
 
 
 
Total LiabilitiesLong Term Debt31.1M49.8M49.9M28.0M
 
 
 
 
 
Other Liabilities0.0018.3K3.2M4.4M
 
 
 
 
Total Liabilities85.9M121.8M124.6M138.8M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.000.000.000.00--
Common Equity48.9M-20.0M41.4M43.0M
 
 
 
 
 
Total Shareholder Equity48.9M-20.0M41.4M43.0M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding112.7M114.5M125.7M128.2M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.